Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price fell 0.5% on Wednesday . The company traded as low as $1.88 and last traded at $1.90. 5,283,343 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 30,834,111 shares. The stock had previously closed at $1.91.
Analyst Ratings Changes
A number of research analysts recently weighed in on TLRY shares. Canaccord Genuity Group cut their price objective on Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research note on Wednesday, April 10th. CIBC decreased their price objective on Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners raised their target price on Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a research report on Friday, April 5th.
View Our Latest Report on TLRY
Tilray Trading Down 2.6 %
The company has a market cap of $1.44 billion, a P/E ratio of -4.23 and a beta of 2.36. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. The business has a 50-day moving average price of $2.05 and a two-hundred day moving average price of $1.96.
Institutional Investors Weigh In On Tilray
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Virtu Financial LLC bought a new stake in shares of Tilray during the first quarter worth $586,000. Tidal Investments LLC grew its stake in Tilray by 36,687.0% in the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company's stock valued at $26,373,000 after acquiring an additional 10,648,403 shares during the period. California State Teachers Retirement System grew its stake in Tilray by 4.4% in the first quarter. California State Teachers Retirement System now owns 678,990 shares of the company's stock valued at $1,677,000 after acquiring an additional 28,586 shares during the period. Bayesian Capital Management LP boosted its position in shares of Tilray by 193.0% during the first quarter. Bayesian Capital Management LP now owns 54,800 shares of the company's stock worth $135,000 after buying an additional 36,100 shares during the period. Finally, Lazard Asset Management LLC bought a new position in shares of Tilray during the first quarter worth about $118,000. Institutional investors own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Articles
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
